Basic fibroblast growth factor (bFGF) is involved in cell proliferation, differentiation, and angiogenesis. It has long been known that bFGF acts as a powerful mitogen for various mammalian granulosa cells in culture. To investigate the possible involvement of bFGF expression in follicle initiation and growth in vivo, we performed nested RT-PCR on ovarian cortical biopsies and quantitative PCR on human follicle populations isolated by laser capture microdissection. Using morphological criteria, follicles were characterized as putative non-growing, primary, or small secondary. RNA was extracted from samples, reverse-transcribed, and relative gene expression levels determined with TaqMane real-time PCR, using 18S rRNA as the endogenous control. Results confirmed bFGF expression in human adult ovarian cortex, and in the isolated follicles a downregulation of bFGF mRNA was evident as small follicles develop. This study demonstrates a possible relationship between bFGF mRNA expression and follicle development.
Introduction
Understanding the mechanisms that initiate and control growth of small follicles remains a major challenge in human ovarian biology. The factors and mechanisms involved in this process are yet to be well-defined. Irrespective of gonadotrophin involvement, there is good evidence that local regulatory factors are implicated in this temporal and spatial process.
Basic fibroblast growth factor (bFGF or FGF-2) was first isolated from bovine pituitary in the 1970s (Gospodarowicz, 1975) . It is a ubiquitous molecule that has received sporadic attention in ovarian biology, yet it is known to be a powerful mitogen for granulosa cells of various species in culture (Gospodarowicz and Bialecki, 1978, 1979; Lavranos et al., 1994; Roberts and Ellis, 1999) . However, two recent in vitro studies have shown contradictory results. In a whole ovary culture system, the addition of bFGF increased the percentage of growing follicles (Nilsson et al., 2001) . In contrast, Derrar et al. (2000) found that bFGF did not change the ratio of growing follicles in an ovarian cortical slice culture system. Unfortunately, these studies did not use robust follicle counting techniques, thus variable follicle distribution in these ovaries was not considered (Hirshfield, 1989) .
Immunohistochemical studies have reported the cellular localization of bFGF protein. The overall consensus indicates its presence in oocytes and granulosa cells of most follicle stages, but the degree of immunostaining reported at specific stages is ambiguous (Grothe and Unsicker, 1989; Wordinger et al., 1993; van Wezel et al., 1995; Yamamoto et al., 1997; Berisha et al., 2000) . A number of bFGF knockout mice exist (Ortega et al., 1998; Zhou et al., 1998; Montero et al., 2000) ; all are viable and fertile, but have neuronal, vascular and skeletal defects. These studies did not investigate detailed reproductive function.
Localization of bFGF mRNA within rat ovarian tissue was studied by Guthridge et al. (1992) , who performed in situ hybridization on ovary slices at different stages of the oestrous cycle and found that both granulosa and thecal cells of large antral and smaller preantral follicles produced bFGF mRNA. Studies of this molecule in human ovary are sparse; although it has been isolated from human fetal ovaries, IVF granulosa extracts, and cultured IVF granulosa cells (Watson et al., 1992; Di Blasio et al., 1993; Yeh and Osthanondh, 1993) . This study was undertaken to investigate bFGF gene expression in adult human ovarian cortex and to quantify bFGF gene expression in isolated small follicles of morphologically distinct stages.
Materials and methods

Tissue collection
Ovarian biopsies were collected from seven healthy fertile women (26-34 years of age) undergoing tubal ligation for fertility control. Informed consent was obtained from all women and the work approved by the Otago Ethics Committee (reference no: 99/12/113). Wedges of ovary measuring ,0.5 cm 3 were halved; one half was immersed in RNAlatere (Ambion Inc., USA) and refrigerated for subsequent RNA extraction, the other half was immediately embedded in O.C.T. cryopreservation compound (Tissue-Tek; Miles, Inc., USA) and stored at 2808C.
RNA extraction and RT of whole biopsies
Biopsies were removed from RNAlatere and the surface epithelium and medullary tissue dissected with a scalpel under a dissecting microscope. The resultant cortical tissue was finely chopped and added to TRIzol w reagent (Invitrogen, USA). To break apart the heavy collagen matrix, specimens were thoroughly homogenized and sonicated. Total RNA was isolated according to standard TRIzol w procedures; RNA was precipitated, washed in 75% ethanol, then dissolved in ribonuclease (RNase)-free Tris -EDTA (pH 8.0). RNA quality was assessed by spectrophotometry and agarose gel electrophoresis. Total RNA (,64 ng) was reverse-transcribed with SuperScripte II first strand synthesis kit (Invitrogen) using oligo deoxythymidine as primer.
Nested PCR and DNA sequencing
All primers were designed for human bFGF from GenBank sequence NM_002006.2. First round PCR was performed using cDNA equivalent of ,10 ng mRNA, 2 IU Platinum w Taq DNA polymerase (Invitrogen), and the outer primers: forward 5 0 -TCTTCCTGCGCATCCACC-3 0 and reverse 5 0 -TCAGCTCTTAGCAGACATTGGAAGA-3 0 in a 50 ml reaction according to manufacturer's protocol. Cycling parameters consisted of an initial denaturing step at 948C for 2 min, then 30 cycles at 948C for 20 s, 588C for 30 s, and 728C for 30 s. An extension step of 728C for 5 min was added at the end of amplification.
Two microlitres of first round product was used as template for another 30 cycles of PCR with the inner primers: forward 5 0 -TGTGCTAACCGTTA-CCTGGCT-3 0 and reverse 5 0 -CAGTGCCACATACCAACTG-3 0 . A 50ml reaction was performed according to the manufacturer's specifications. Cycling parameters were the same as above except that an annealing temperature of 598C was used.
Nested PCR products were visualized by agarose gel electrophoresis. Products were purified using the Qiagen PCR purification kit (Qiagen, Canada), and sequenced (ABI377 DNA sequencer; Applied Biosystems, USA).
Laser capture microdissection (LCM)
LCM is a method of isolating specific cell populations from tissue sections using a laser mounted on an inverted research microscope (PixCell w II; Arcturus, USA). Sections (8 mm) were cut at 2208C from O.C.T.-embedded biopsies and mounted on RNase-free slides. After brief fixation in 70% ethanol, sections were stained with Histogene staining solution (Arcturus), and dehydrated to xylene. Slides were stored in desiccated containers until LCM.
Before isolation, follicles present in the section were microscopically classified using morphological criteria similar to those described by Gougeon (1996) . Human primordial and transitory follicles were categorized by the presence of squamous granulosa cells and subsequently classed as putative non-growing follicles; when the oocyte was clearly surrounded by a complete layer of cuboidal granulosa cells, the follicle was classed as a primary follicle. Small secondary follicles had more than one layer of granulosa cells.
Laser pulses were fired at oocytes and granulosa cells of selected follicles; the disposable tissue collection cap (High-sensitivity caps, Arcturus) and micro-dissected tissue were lifted away from the section (Figure 1 ). The physical size limitations of the laser beam precluded the dissection of individual follicle cells. Due to the small amount of tissue (and thus mRNA), LCM-harvested follicle cells were pooled for each follicle type from each individual patient.
RNA extraction and RT of isolated follicles
Captured tissue was incubated in PicoPuree extraction buffer (Arcturus) at 428C for 30 min. Total RNA was isolated using the PicoPuree RNA isolation kit (Arcturus) according to the manufacturer's instructions. As the total RNA extracted from these samples was extremely limited, no attempt was made to quantify the amount of RNA in the sample. Consequently, the entire sample was used in subsequent RT reactions. RT was undertaken as above, except that random hexamers were used as primers.
Comparative C T method for relative quantification of gene expression
Duplicate multiplex reactions were carried out on follicle samples using the ABI TaqMane bFGF primer/probe set with FAM dye labelling the probe (Assay-on-Demande Hs00266645_m1; Applied Biosystems). The normalizer 18S was used, labelled with the fluorescent dye VIC (Pre-developed TaqMane Assay; Applied Biosystems). Primer concentrations were pre-limited for multiplex reactions.
Thirty microlitre reactions were prepared in 96-well optical reaction plates with optical adhesive covers (ABI Prisme Applied Biosystems) using TaqMane Universal PCR Master Mix (Applied Biosystems). Using the ABI Prism w 7000 (Applied Biosystems), samples were heated to 508C for 2 min, then 958C for 10 min before 40 cycles at 958C for 15 s and 608C for 1 min as per manufacturer's instructions.
Real-time data were analysed using the comparative C T method: where C T is the cycle number at which the fluorescence reading is first recorded above background levels (Bustin, 2000) . The comparative C T method is similar to the standard curve method, except that it uses the arithmetic formula, 2 -DDCT to achieve relative quantification (for detailed information see Applied Biosystems' User Bulletin #2). A prior validation experiment was performed to demonstrate that amplification efficiencies of bFGF and 18S primer/probe sets were approximately equal: efficiencies were within 0.1 (data not shown).
Evaluation of sample specificity
To confirm purity of LCM isolates, separate samples of ovarian stromal cells were isolated via LCM. RNA extraction and RT was performed as for follicle cell preparations. Sample purity was confirmed by standard PCR with primers for FSH receptor and cytochrome P450 17a-hydroxylase (P450c17). Primer details and annealing temperatures for PCR are summarized in Table I .
Statistical analysis of comparative C T method for relative quantification
As multiplex reactions occur in the same tube, raw bFGF C T data are firstly normalized by subtracting the corresponding 18S C T . Duplicates are then averaged to give the mean DC T . The comparative C T method is a relative measure of mRNA expression, thus one of the samples can be used as a calibrator. Here the putative non-growing follicle samples were chosen to be the calibrator for each individual. Subtracting the DC T for putative nongrowing follicles from the DC T of all samples gave the relative change (DDC T ).
It is important to note that relative comparisons were only made between follicle types within the same patient (intra-personal variation).
Slopes calculated from the regression line for each patient were used in a one-sample t-test, testing against zero.
Results
Confirmation of bFGF gene expression in human cortical extracts
To study expression of bFGF in human ovary cortical extracts, nested RT-PCR was performed. This resulted in a product of the expected 150 bp length (Figure 2a, lane 3) . Sequencing confirmed that the 150 bp product corresponded to the appropriate part of GenBank sequence NM_002006.2 (Figure 2b ). This fragment crosses an intron/exon boundary and thus established that the product was mRNA in origin. The fact that nested PCR was required to detect bFGF indicated that expression of this gene was low.
Relative quantification of bFGF gene expression across follicle stages
Specific follicle populations were isolated from ovarian biopsies from seven women using LCM. Due to the nature of human material each biopsy contained variable populations of follicle types, and thus for every patient studied different follicle types were isolated (summarized in Table II) . Table III shows the results from the real-time PCR for these samples. All seven patients showed a down-regulation of bFGF expression across early follicle development.
To demonstrate these trends, the mean of individual slopes for each patient is presented in Figure 3 . 
Confirmation of sample specificity
To test the specificity of our LCM method, four different genes were used as cell markers (Figure 4) . b-Actin (750 bp) and bFGF (150 bp) were found in all the RT þ samples (cortical extract, oocyte/granulosa cells from small follicles, and stroma). FSH receptor (340 bp; granulosa cell marker) was detected in ovarian cortex and the small follicle sample, but not in the stromal LCM sample, indicating that the small follicle sample contained granulosa cells. P450c17 (418 bp; an enzyme found in steroid-producing cells such as thecal or stromal tissue) was detected in ovarian cortex, and the stromal sample. The small follicle sample was negative for P450c17, demonstrating that surrounding stromal material did not contaminate preparations of oocytes and granulosa cells.
Discussion
In this study, putative non-growing, primary, and small secondary follicles have, for the first time, been isolated by laser microdissection. This isolation technique provides an opportunity to study gene expression at specific stages of follicle development from snapfrozen human biopsies. We report here that bFGF was not only expressed by adult ovarian cortex, but that bFGF mRNA was present in small follicles and expression decreased over early follicle development. bFGF gene expression has been reported in human fetal ovaries (Yeh and Osathanondh, 1993) and we confirm bFGF mRNA expression in healthy adult ovarian cortex. In earlier studies, there was uncertainty regarding the detection of bFGF transcripts (Neufeld et al., 1987; Koos and Olson, 1989; Stirling et al., 1991) , but with technical advances it is now evident that bFGF is expressed in cultured and freshly prepared granulosa cells of large follicles from many different species (Guthridge et al., 1992 ; Watson et al., Table III . Relative quantitative PCR measurements for bFGF mRNA expression normalized to 18S (see Figure 3) Patient no.
Putative non-growing Primary 1992; Berisha et al., 2000; Shimizu et al., 2002) . Here, in the human, we have shown that small ovarian follicles express the gene for bFGF.
By using real-time PCR, we not only demonstrated bFGF mRNA expression in the smallest follicles, but also compared relative expression levels across early follicle growth. All seven patients showed the same decreasing trend in bFGF mRNA expression. The only other study to investigate bFGF mRNA expression across early follicle development used in situ hybridization, which localized the mRNA for bFGF in granulosa cells and theca cells of rat preantral follicles (Guthridge et al., 1992) . Similarly, here we report bFGF mRNA in small follicles in human specimens and further suggest a down-regulation of the mRNA during early follicle growth.
The LCM isolation technique has allowed the clear separation of granulosa cells and oocytes from surrounding theca or stromal tissue with minimum manipulation. The purity of LCM sample preparation was tested using standard RT-PCR. The detection of FSH receptor and P450c17 in follicle and stromal samples respectively indicates that laser microdissection precisely isolated follicle samples from ovarian sections. This technique is especially useful in human material as the adult ovary is extremely collagenous and sparsely populated with follicles. Alternative small follicle isolation techniques would be impractical for gene expression studies unless undesirable mechanical or protease treatments as well as extended incubations are used (Oktay et al., 1997) .
A number of immunohistochemical studies reported high levels of bFGF protein in the oocyte (van Wezel et al., 1995; Nilsson et al., 2001) , whereas others were unable to detect bFGF in oocytes at all (Wordinger et al., 1993) . This highlights the variability inherent in immunodetection. We would have liked to use LCM to clarify whether bFGF mRNA was found in oocytes or granulosa cells, but due to the physical limitations of the laser, more detailed dissection of the follicle (i.e. oocytes as distinct from granulosa cells) was considered unreliable and not performed. To investigate cellular sources of bFGF mRNA further, in situ hybridization on human ovarian biopsies is currently in progress.
It is interesting to speculate on the role of bFGF in follicle development and, in light of these findings, what its specific function might be in small follicles. Many groups have shown that bFGF has angiogenic properties (Bikfalvi et al., 1997) ; but since very small follicles have no direct blood supply it is unlikely that the relatively increased levels of bFGF mRNA in the putative non-growing follicles reported here relate to angiogenesis. bFGF has been previously implicated in inhibitory interactions with the gonadotrophin receptors LH and FSH (Mondschein and Schomberg, 1981; Biswas et al., 1988; Yamoto et al., 1993; Kanzaki et al., 1994) . The downregulation of bFGF message in early follicle development reported here provides evidence for bFGF as an inhibitor of follicle growth through attenuation of gonadotrophin receptor induction. To date there is little direct or convincing evidence for apoptosis in primordial follicles; our finding of higher levels of bFGF mRNA in putative non-growing follicles supports the hypothesis that bFGF could inhibit apoptosis (Lynch et al., 2000) . Our results indicate a role for bFGF in small human ovarian follicles that requires further investigation.
